THROMBUS IMAGING WITH RADIOLABELED PEPTIDES

Information

  • Research Project
  • 2225089
  • ApplicationId
    2225089
  • Core Project Number
    R43HL048986
  • Full Project Number
    1R43HL048986-01A2
  • Serial Number
    48986
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/30/1993 - 33 years ago
  • Project End Date
    4/14/1994 - 32 years ago
  • Program Officer Name
  • Budget Start Date
    9/30/1993 - 33 years ago
  • Budget End Date
    4/14/1994 - 32 years ago
  • Fiscal Year
    1993
  • Support Year
    1
  • Suffix
    A2
  • Award Notice Date
    9/25/1993 - 33 years ago
Organizations

THROMBUS IMAGING WITH RADIOLABELED PEPTIDES

Deep vein thrombosis (DVT) and resultant pulmonary emboli (PE) represent significant morbidity and mortality in the USA. Existing detection modalities such as contrast venography, ultrasound, and non-specific radiopharmaceuticals do not exhibit the sensitivity or specificity in all areas of interest to reliably detect DVT or PE. A Tc-99m radiolabeled thrombus-binding peptide would be ideally suited to this task by virtue of its specificity, favorable pharmacokinetics, low-cost isotope and widely available nuclear medicine facilities. As platelets are a component of thrombi, synthetic peptides that bind with high affinity to the GPIIb/IIIa receptor on the surface of activated platelets provide a rational basis for the development of a thrombus- specific radiopharmaceutical. We now have preliminary in vitro and in vivo data that indicate that this is a viable approach. We propose to build on our initial work by synthesizing additional Tc-99m labeleable peptides with improved thrombus-binding and pharmacokinetic characteristics and to evaluate them in vitro and in animal models of DVT and PE. The peptide(s) exhibiting optimal characteristics will be selected for biodistribution and toxicological studies in support of clinical trials for the diagnosis of DVT and PE.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    DIATIDE, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    LONDONDERRY
  • Organization State
    NH
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    03053
  • Organization District
    UNITED STATES